Clinical Trial Update: Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing conventional-dose chemotherapy with high-dose sequential chemotherapy for poor-prognosis germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors
• Testicular Cancer

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Testicular Neoplasms, Germ Cell Tumors | Phase 2 | Status: COMPLETED